Company / R&D per Share
COMPASS Pathways plc R&D per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.76
FY2024
5-year range
$1.10 / $1.76
FY2020-FY2024
Trend
+2.9%
vs FY2023
Sector context
#110 of 208
Health Care
What the data says
At $1.76, COMPASS Pathways plc's r&d per share ranks #110 of 208 in the Health Care sector. R&D per Share has increased for 3 consecutive years, from $1.10 in FY2021 to $1.76 in FY2024.
Based on SEC 10-K filings.
1.76 in FY2024 with a 5-year CAGR of +1.0%.
Improved from $1.53 to $1.76 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +17.0%
- 5-Year CAGR
- +1.0%
- 10-Year CAGR
- -
Sector benchmark
#110 of 208 in Health CareTop 53% of 208This company $1.76 Sector average $28.77
▼
-93.9% below sector average
Key checks
Key Insights
- COMPASS Pathways plc's r&d per share has grown for 3 consecutive years.
- In FY2024, r&d per share increased 2.9% year-over-year.
- Ranks #110 out of 208 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.76 | +2.9% |
| FY2023 | $1.72 | +11.9% |
| FY2022 | $1.53 | +39.3% |
| FY2021 | $1.10 | -20.0% |
| FY2020 | $1.38 | -18.2% |
| FY2019 | $1.68 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026